Atrial Fibrillation

Clinical Trials

Below is a list of Atrial Fibrillation clinical trials from the clinical trials database at Mayo Clinic.

This list includes only trials about which Mayo researchers choose to publish information. Mayo Clinic may be conducting other trials which are not in this database. Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.

Positive Airway Pressure Therapy in Atrial Fibrillation Recurrence in Obstructive Sleep Apnea
This research study is being done to study the effect of treatment of sleep apnea on:

• the rate of recurrence of atrial fibrillation (AF) after cardioversion
• quality of life following cardioversion
• blood pressure following cardioversion
• changes in blood markers of cardiovascular disease

WATCHMAN ® Left Atrial Appendage Filter System for Embolic PROTECTion in Patients with Atrial Fibrillation (PROTECT AF)
This study is being done to find out what effects the WATCHMAN Left Atrial Appendage System has on you and your heart and to assess the safety and effectiveness of the device compared to patients who receive blood thinning medication called warfarin (or Coumadin).

This trial is a randomized trial in which participants will be put into one of two groups by chance (as in the flip of a coin). One group will receive standard medical therapy that involves the use of the blood-thinning medication called warfarin (Coumadin). The other group will have an investigational device called the WATCHMAN Left Atrial Appendage device permanently implanted in their heart.
Read more